Therapeutic Asset Ratings

567 results matching 1 filter

129,767 assets · 8,707 sponsors · 3,128 indications

Methodology v0.2

Asset	Sponsor	Phase	Rating
FILGRASTIM Lymphoplasmacytic Lymphoma	Fred Hutchinson Cancer Center	P2	B (57)
Fludarabine GATA2 Deficiency With Susceptibility To MDS/AML	Fred Hutchinson Cancer Center	P2	B (57)
Fludarabine SAMD9L-Related Spectrum And Myeloid Neoplasm Risk	Fred Hutchinson Cancer Center	P2	B (57)
Fludarabine SAMD9-Related Spectrum And Myeloid Neoplasm Risk	Fred Hutchinson Cancer Center	P2	B (57)
Fludarabine Inherited Sideroblastic Anemia	Fred Hutchinson Cancer Center	P2	B (57)
METHOTREXATE Burkitt Leukemia	Fred Hutchinson Cancer Center	P2	B (57)
METHOTREXATE GATA2 Deficiency With Susceptibility To MDS/AML	Fred Hutchinson Cancer Center	P2	B (57)
METHOTREXATE SAMD9L-Related Spectrum And Myeloid Neoplasm Risk	Fred Hutchinson Cancer Center	P2	B (57)
METHOTREXATE SAMD9-Related Spectrum And Myeloid Neoplasm Risk	Fred Hutchinson Cancer Center	P2	B (57)
METHOTREXATE Inherited Sideroblastic Anemia	Fred Hutchinson Cancer Center	P2	B (57)
Mitoxantrone Acute Leukemia Of Ambiguous Lineage	Fred Hutchinson Cancer Center	P2	B (57)
Monomethyl Fumarate Blastic Plasmacytoid Dendritic Cell Neoplasm	Fred Hutchinson Cancer Center	P2	B (57)
Nivolumab Head And Neck Neoplasm	Fred Hutchinson Cancer Center	P2	B (57)
TACROLIMUS CD4+/CD56+ Hematodermic Neoplasm	Fred Hutchinson Cancer Center	P2	B (57)
TACROLIMUS GATA2 Deficiency With Susceptibility To MDS/AML	Fred Hutchinson Cancer Center	P2	B (57)
TACROLIMUS SAMD9L-Related Spectrum And Myeloid Neoplasm Risk	Fred Hutchinson Cancer Center	P2	B (57)
TACROLIMUS SAMD9-Related Spectrum And Myeloid Neoplasm Risk	Fred Hutchinson Cancer Center	P2	B (57)
TACROLIMUS Inherited Sideroblastic Anemia	Fred Hutchinson Cancer Center	P2	B (57)
Thiotepa Acute Leukemia Of Ambiguous Lineage	Fred Hutchinson Cancer Center	P2	B (57)
Thiotepa CD4+/CD56+ Hematodermic Neoplasm	Fred Hutchinson Cancer Center	P2	B (57)
Thiotepa Blasts Under 5 Percent of Bone Marrow Nucleated Cells	Fred Hutchinson Cancer Center	P2	B (57)
Thiotepa Hematologic Neoplasm With Germline GATA2 Mutation	Fred Hutchinson Cancer Center	P2	B (57)
Thiotepa Hematologic Neoplasm With Germline SAMD9L Mutation	Fred Hutchinson Cancer Center	P2	B (57)
Thiotepa Hematologic Neoplasm With Germline SAMD9 Mutation	Fred Hutchinson Cancer Center	P2	B (57)
Thiotepa Hereditary Sideroblastic Anemia	Fred Hutchinson Cancer Center	P2	B (57)

Showing 226 to 250 of 567 assets

PreviousPage 10 of 23Next